About tau

Manuscript Submission

AME Editing Service

Reprint & Permission


Contact us



Original Article

Real-world clinical effectiveness of nonsurgical treatments for female with POP-Q stage II cystocele: a retrospective analysis of therapeutic efficacy
Cuiping Jin, Hongliang Yan, Yumin Shang, Chaoqun Dong, Pengfei Li, Yang Tang, Fuling Ma, Yuanjie Niu
Survival nomogram and risk classification system for patients with adrenocortical carcinoma: a study based on the SEER database and external validation in China
Zhizhou Li, Maoyu Wang, Wei Gang, Yidie Ying, Ziwei Wang, Qing Chen, Xufeng Yu, Wei He, Shuxiong Zeng, Zhensheng Zhang, Chuanliang Xu, Huiqing Wang
Identification of a lactate metabolism-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma
Tianzi Xu, Yixin Liu, Biao Ning, Min Luo, Yongchang Wei
Porous Se@SiO2 nanocomposites play a potential inhibition role in hyperoxaluria associated kidney stone by exerting antioxidant effects
Chen Ye, Lin Zhao, Jiaying Miao, Chengyu Gong, Yuangui Chen, Shengfei Qin, Nicholas N. Tadros, Stefan Aufderklamm, Wenli Jiang, Guoying Deng, Shaoxiong Ming
Nitro-oleic acid (NO2-OA) ameliorates erectile dysfunction in a rat model of diabetes mellitus via modulation of fibrosis, inflammation and autophagy
Changbo Zhao, Weibo Chen, Fangxin Gong, Wenzhen Wang, Cuiqin Fan, Ye Li, Tian Lan, Wenjing Wang, Mingzhen Yuan
Differential effects of obesity on perioperative outcomes in renal cell carcinoma patients based on race and ethnicity and neighborhood-level socioeconomic status
Waheed Asif, Irasema C. Paster, Kathryn R. Pulling, Kyle Garcia, Patrick Wightman, Alejandro Cruz, Christopher Combates, Eric C. Kauffman, Francine C. Gachupin, Benjamin R. Lee, Juan Chipollini, Ken Batai

Editorial Commentary

European association of urology biochemical recurrence risk stratification in the context of post-prostatectomy salvage therapy
Timothy A. Lin, Daniel Y. Song
Metabolic enzymes moonlighting to drive enzalutamide resistance in prostate cancer
Maria Rusan, Simone Weiss, Karina Dalsgaard Sørensen
Effectiveness of switch therapy from tyrosine kinase inhibitors to immune checkpoint inhibitors: the need for biomarkers to establish treatment strategies in patients with metastatic renal cell carcinoma
Yoshihiko Tasaki, Shuzo Hamamoto, Yoko Furukawa-Hibi, Takahiro Yasui
Refining the subgroup analyses and optimal patient population in the JAVELIN Bladder 100 trial
Jeanny B. Aragon-Ching
Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?
Daniel A. González-Padilla, José Daniel Subiela, Felipe Villacampa-Aubá
Management of small renal mass: unmet needs and quest for high quality evidence
Leslie Claire Licari, Eugenio Bologna, Riccardo Autorino
Ablative therapy with UGN-102 for low-grade intermediate risk non-muscle-invasive bladder cancer: ready for primetime?
Benjamin Lichtbroun, Saum Ghodoussipour, Vignesh T. Packiam
What is the key factor determining effectiveness of radiotherapy for high-risk prostate cancer: a hidden message from RTOG 0521
Keisei Okamoto
A critical evaluation of Optilume® BPH as a novel minimally invasive surgical treatment for the management of lower urinary tract symptoms in men
David C. Chen, Alice Thomson, Siyu Huang, Declan G. Murphy, Damien Bolton, Nathan Lawrentschuk, Marlon L. Perera

Original Article

Surgical treatment of Peyronie’s disease by modified 16-dot placation in China
Wen Ji Li, Haijun Yao, Ke Zhang, Zhikang Cai, Jun Da, Mingxi Xu, Zhong Wang
Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
Sherif Azab, Ayman Osama, Mona Rafaat

Review Article

Strategies for maintaining penile size following penile implant
King Chien Joe Lee, Gerald B. Brock
Phalloplasty for the genetic male
Giulio Garaffa, Gabriele Antonini, Vincenzo Gentile, David J. Ralph
Exogenous testosterone: a preventable cause of male infertility
Lindsey E. Crosnoe, Ethan Grober, Dana Ohl, Edward D. Kim
Premature ejaculation: do we have effective therapy?
Ege Can Serefoglu, Theodore R. Saitz, Landon Trost, Wayne J.G. Hellstrom
Peyronie’s disease: current therapy
Clay M. Pendleton, Run Wang

Expert Opinions on Challenging Cases

Commentary on the myths of Peyronie’s disease
Alex K Wu, Tom F Lue


Randall plaque versus renal stone?
Thomas Chi, Joe Miller, Marshall L. Stoller

Original Article

Overall satisfaction, sexual function, and the durability of neophallus dimensions following staged female to male genital gender confirming surgery: the Institute of Urology, London U.K. experience
Maurice M. Garcia, Nim A. Christopher, Francesco De Luca, Marco Spilotros, David J. Ralph
Incidence of urinary extravasation and rate of ureteral stenting after high-grade renal trauma in adults: a meta-analysis
Sorena Keihani, Ross E. Anderson, Michelle Fiander, Mary M. McFarland, Gregory J. Stoddard, James M. Hotaling, Jeremy B. Myers
Safety and efficacy of daily Revactin® in men with erectile dysfunction: a 3-month pilot study
Sabine Nguyen, Jacob Rajfer, Magda Shaheen

Review Article

Future perspectives of prostate cancer therapy
Murali Gururajan, Edwin M. Posadas, Leland W. K. Chung
Small RNA and its application in andrology and urology
Ji Wang, Long-Cheng Li
TGF-β mediated DNA methylation in prostate cancer
Chung Lee, Qiang Zhang, Xaolin Zi, Atreya Dash, Marcelo B Soares, Farahnaz Rahmatpanah, Zhenyu Jia, Michael McClelland, Dan Mercola
Cystine nephrolithiasis
Hasan Fattah, Yasmin Hambaroush, David S. Goldfarb
Kidney stone risk following Roux-en-Y gastric bypass surgery
Benjamin K. Canales, Ricardo D. Gonzalez
Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis
Saeed R. Khan
Outlining the limits of partial nephrectomy
Sameer Chopra, Raj Satkunasivam, Chandan Kundavaram, Gangning Liang, Inderbir S. Gill
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
Thenappan Chandrasekar, Joy C. Yang, Allen C. Gao, Christopher P. Evans
Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics
Shabnam Ziaee, Gina Chia-Yi Chu, Jen-Ming Huang, Shirly Sieh, Leland W. K. Chung
Inflammation in prostate cancer progression and therapeutic targeting
Timothy Stark, Lydia Livas, Natasha Kyprianou
Sympathetic nervous system and chronic bladder pain: a new tune for an old song
Ana Charrua, Rui Pinto, Lori Ann Birder, Francisco Cruz
Angiogenic factors, bladder neuroplasticity and interstitial cystitis—new pathobiological insights
Ricardo Saban
Increased bladder permeability in interstitial cystitis/painful bladder syndrome
Robert E. Hurst, Beverley Greenwood-Van Meerveld, Amy B. Wisniewski, Samuel VanGordon, Hsueh Kung Lin, Bradley P. Kropp, Rheal A. Towner
Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy
Fei Yang, John C. Ford, Nesrin Dogan, Kyle R. Padgett, Adrian L. Breto, Matthew C. Abramowitz, Alan Dal Pra, Alan Pollack, Radka Stoyanova


PIVOT and the challenges of localized prostate cancer care
Aviva E. Weinberg, James D. Brooks

Research Highlights

Enzalutamide: the emperor of all anti-androgens
Emmanuel S. Antonarakis

Review Articles

Androgen receptor gene mutation, rearrangement, polymorphism
Kurtis Eisermann, Dan Wang, Yifeng Jing, Laura E. Pascal, Zhou Wang
Androgen receptor epigenetics
Changmeng Cai, Xin Yuan, Steven P. Balk
Androgen receptor genomic regulation
Hong-Jian Jin, Jung Kim, Jindan Yu
Decoding the androgen receptor splice variants
Changxue Lu, Jun Luo
Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
Campbell M. Grant, Natasha Kyprianou
Steroid hormone synthetic pathways in prostate cancer
Elahe A. Mostaghel
Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer
Jason Wu, Dongfeng Pan, Leland W.K. Chung

Review Article: Hypospadias

Do endocrine disruptors cause hypospadias?
Sisir Botta, Gerald R. Cunha, Laurence S. Baskin

Below are the latest Translational Andrology and Urology articles published online ahead of print publication.